Format
Sort by
Items per page

Send to

Choose Destination

Best matches for DULOXETINE/TU:

Search results

Items: 1 to 20 of 147

1.

Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia.

Welsch P, Üçeyler N, Klose P, Walitt B, Häuser W.

Cochrane Database Syst Rev. 2018 Feb 28;2:CD010292. doi: 10.1002/14651858.CD010292.pub2. Review.

2.

Combination pharmacotherapy for the treatment of fibromyalgia in adults.

Thorpe J, Shum B, Moore RA, Wiffen PJ, Gilron I.

Cochrane Database Syst Rev. 2018 Feb 19;2:CD010585. doi: 10.1002/14651858.CD010585.pub2. Review.

PMID:
29457627
3.

Pharmacotherapy for Neuropathic Pain in Japan.

Masuda R, Ajimi J, Murata T.

J Nippon Med Sch. 2017;84(6):258-267. doi: 10.1272/jnms.84.258. Review.

4.

A rat model of FOLFOX-induced neuropathy: effects of oral dimiracetam in comparison with duloxetine and pregabalin.

Di Cesare Mannelli L, Maresca M, Micheli L, Farina C, Scherz MW, Ghelardini C.

Cancer Chemother Pharmacol. 2017 Dec;80(6):1091-1103. doi: 10.1007/s00280-017-3449-8. Epub 2017 Oct 12.

PMID:
29026967
5.

Repeated Administration of Duloxetine Suppresses Neuropathic Pain by Accumulating Effects of Noradrenaline in the Spinal Cord.

Ito S, Suto T, Saito S, Obata H.

Anesth Analg. 2018 Jan;126(1):298-307. doi: 10.1213/ANE.0000000000002380.

PMID:
28787337
6.

Predictors of the usefulness of duloxetine for chemotherapy-induced peripheral neuropathy.

Kanbayashi Y, Inagaki M, Ueno H, Hosokawa T.

Med Oncol. 2017 Aug;34(8):137. doi: 10.1007/s12032-017-0995-1. Epub 2017 Jul 7.

PMID:
28687964
7.

Vortioxetine for depression in adults.

Koesters M, Ostuzzi G, Guaiana G, Breilmann J, Barbui C.

Cochrane Database Syst Rev. 2017 Jul 5;7:CD011520. doi: 10.1002/14651858.CD011520.pub2. Review.

PMID:
28677828
8.

Duloxetine Plasma Concentrations and Its Effectiveness in the Treatment of Nonorganic Chronic Pain in the Orofacial Region.

Kobayashi Y, Nagashima W, Tokura T, Yoshida K, Umemura E, Miyauchi T, Arao M, Ito M, Kimura H, Kurita K, Ozaki N.

Clin Neuropharmacol. 2017 Jul/Aug;40(4):163-168. doi: 10.1097/WNF.0000000000000225.

PMID:
28622208
9.

Advances in the management of diabetic neuropathy.

Várkonyi T, Körei A, Putz Z, Martos T, Keresztes K, Lengyel C, Nyiraty S, Stirban A, Jermendy G, Kempler P.

Minerva Med. 2017 Oct;108(5):419-437. doi: 10.23736/S0026-4806.17.05257-0. Epub 2017 May 25. Review.

PMID:
28541026
10.
11.

Adverse effects and treatment satisfaction among online users of four antidepressants.

Hughes S, Lacasse J, Fuller RR, Spaulding-Givens J.

Psychiatry Res. 2017 Sep;255:78-86. doi: 10.1016/j.psychres.2017.05.021. Epub 2017 May 16.

PMID:
28531820
12.

Spinal dopaminergic involvement in the antihyperalgesic effect of antidepressants in a rat model of neuropathic pain.

Chen M, Hoshino H, Saito S, Yang Y, Obata H.

Neurosci Lett. 2017 May 10;649:116-123. doi: 10.1016/j.neulet.2017.04.017. Epub 2017 Apr 14.

PMID:
28416380
13.

Effects of Patient Preferences on Outcomes in the Predictors of Remission in Depression to Individual and Combined Treatments (PReDICT) Study.

Dunlop BW, Kelley ME, Aponte-Rivera V, Mletzko-Crowe T, Kinkead B, Ritchie JC, Nemeroff CB, Craighead WE, Mayberg HS; PReDICT Team.

Am J Psychiatry. 2017 Jun 1;174(6):546-556. doi: 10.1176/appi.ajp.2016.16050517. Epub 2017 Mar 24.

PMID:
28335624
14.

Functional Connectivity of the Subcallosal Cingulate Cortex And Differential Outcomes to Treatment With Cognitive-Behavioral Therapy or Antidepressant Medication for Major Depressive Disorder.

Dunlop BW, Rajendra JK, Craighead WE, Kelley ME, McGrath CL, Choi KS, Kinkead B, Nemeroff CB, Mayberg HS.

Am J Psychiatry. 2017 Jun 1;174(6):533-545. doi: 10.1176/appi.ajp.2016.16050518. Epub 2017 Mar 24. Erratum in: Am J Psychiatry. 2017 Jun 1;174(6):604.

PMID:
28335622
15.

Levetiracetam synergizes with gabapentin, pregabalin, duloxetine and selected antioxidants in a mouse diabetic painful neuropathy model.

Stepanović-Petrović R, Micov A, Tomić M, Pecikoza U.

Psychopharmacology (Berl). 2017 Jun;234(11):1781-1794. doi: 10.1007/s00213-017-4583-z. Epub 2017 Mar 22.

PMID:
28332005
16.
17.

Considering benefits and harms of duloxetine for treatment of stress urinary incontinence: a meta-analysis of clinical study reports.

Maund E, Guski LS, Gøtzsche PC.

CMAJ. 2017 Feb 6;189(5):E194-E203. doi: 10.1503/cmaj.151104. Epub 2016 Nov 14.

18.

Reevaluating the Efficacy and Predictability of Antidepressant Treatments: A Symptom Clustering Approach.

Chekroud AM, Gueorguieva R, Krumholz HM, Trivedi MH, Krystal JH, McCarthy G.

JAMA Psychiatry. 2017 Apr 1;74(4):370-378. doi: 10.1001/jamapsychiatry.2017.0025.

19.

Severe Venlafaxine Withdrawal Successfully Treated With a Short Course of Duloxetine.

Cutler N.

Prim Care Companion CNS Disord. 2017 Feb 9;19(1). doi: 10.4088/PCC.16l02001. No abstract available.

20.

Changing general medical practices in the management of neuropathic pain

Poucher M, Cherrier C, Poucher AC, Di Patrizio P.

Sante Publique. 2016 Oct 19;28(4):505-516. French.

PMID:
28155755

Supplemental Content

Loading ...
Support Center